Lydian is one of Belgium's leading independent law firms. Capitalizing on the opportunities presented by the merger of large Belgian law firms into international networks, Lydian has successfully evolved into a fully-fledged, stand-alone business law firm. The firm is powered by a team of 90 motivated and highly competent lawyers working out of its offices in Brussels, Hasselt, and Antwerp.

Lydian provides advice on a wide range of Belgian business law matters, with a particular specialization in Intellectual Property law and trade practices. The firm's IP & IT team represents numerous prestigious international companies, handling both day-to-day and complex intellectual property and trade practices issues across various industry sectors, including luxury goods, media, entertainment, life sciences, IT, telecom, and insurance.

The firm's practice covers all aspects related to the launch and marketing of products and services, such as advertising, product regulations, consumer protection, distribution, franchising, privacy, and e-commerce. Additionally, Lydian excels in the exploitation and protection of intellectual property rights, including trademarks, copyright, domain names, design, licenses, and patents. The firm also has extensive experience in litigation and negotiations, advising clients on how to avoid disputes or how to effectively respond to and resolve litigation, often involving regulatory authorities.

Lydian frequently handles referral cases from prestigious law firms outside Belgium and counts among its clients leading large and medium-sized Belgian and international companies.

In summary:

• 35 employees
• 90 fee-earners
• 13 partners
• Offices in Brussels, Hasselt, and Antwerp
• Expertise across 12 practice areas, including Corporate & Finance, Employment, Pension & Benefit, Real Estate, Energy & Regulatory, Commercial & Litigation, Insurance & Reinsurance, Fraud & Investigation, Information Communication Technology, Information Governance & Data Governance, Intellectual Property, Media, Health, and Life Sciences.